There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for CVS Health Corporation (CVS) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.0313, or -0.04%, to $89.3387. The CVS Health Corporation has recorded 438,122 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted CVS Health to Hold Fourth Quarter and Full-Year 2022 Earnings Conference Call.
This NYSE-listed company operates within the Healthcare Plans industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $89.37 and fluctuated between $90.56 as its day high and $89.11 as its day low. The current market capitalization of CVS Health Corporation is $116.46B. A total of 12.31 million shares were traded on the day, compared to an average of 6.46M shares.
Insider trades can also provide insight into a stock’s future direction. During the recent three months, CVS has seen 6 BUY and 2 SELL insider trades, representing the acquisition of 7,009 and the disposition of 595 shares. Over the last 12 months, there were 52 BUYs and 44 SELLs from insiders. Insiders purchased 2,452,481 shares during that period but sold 985,450.
In the most recent transaction, Moriarty Thomas M sold 137,466 shares of CVS for 98.36 per share on Dec 15. After the transaction, the EVP & General Counsel now owns 608,129 company shares. In a previous transaction on Aug 04, Lotvin Alan sold 22,541 shares at 104.00 per share. CVS shares that EVP&President-PharmacyServices owns now total 109,183.
Among the insiders who sold shares, Lotvin Alan disposed of 120,899 shares on Aug 03 at a per-share price of $98.00. This resulted in the EVP&President-PharmacyServices holding 109,183 shares of CVS after the transaction. In another insider transaction, Finke Daniel P sold 9,546 shares at $100.00 per share on Aug 03. Company shares held by the EVP/Pres, Health Care Benefits now total 32,150.
The income generated by dividends is an indication that a company is improving its financial position, which is why investors prefer companies paying dividends. CVS Health Corporation pays an annual dividend of $2.42, resulting in a dividend yield of 2.71%, and it has a price to earnings (P/E) ratio of 37.98. CVS’s most recent ex-dividend date was 1/19/2023 when it declared a $0.6050 quarterly dividend that was paid in cash on 2/1/2023. Previously, the company paid the dividend on 11/1/2022 with an ex-dividend date of 10/20/2022. The CVS stock dividend was $0.55 per share in cash.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for CVS in the last 3 months, the mean price target is $114.18 with high estimates of $130.00 and low estimates of $92.55. In terms of 52-week highs and lows, CVS has a high of $111.25 and a low of $86.28.
As of this writing, CVS has an earnings estimate of $1.99 per share for the current quarter. EPS was calculated based on a consensus of 21 estimates, with a high estimate of $2.08 per share and a lower estimate of $1.92. The company reported an EPS of $2.22 in the last quarter, which was 3.30% higher than expectations of $2.15.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 24 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CVS is Sell with a score of 4.35. A total of 14 analysts rated the stock as Buy while 4 rated it as Overweight while 6 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.